Your browser doesn't support javascript.
loading
Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in Dengue.
Aggarwal, Charu; Saini, Keshav; Reddy, Elluri Seetharami; Singla, Mohit; Nayak, Kaustuv; Chawla, Yadya M; Maheshwari, Deepti; Singh, Prabhat; Sharma, Pragati; Bhatnagar, Priya; Kumar, Sanjeev; Gottimukkala, Kamalvishnu; Panda, Harekrushna; Gunisetty, Sivaram; Davis, Carl W; Kissick, Haydn Thomas; Kabra, Sushil Kumar; Lodha, Rakesh; Medigeshi, Guruprasad R; Ahmed, Rafi; Murali-Krishna, Kaja; Chandele, Anmol.
Afiliación
  • Aggarwal C; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Saini K; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Reddy ES; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Singla M; Kusuma School of Biological Sciences, Indian Institute of Technology, New Delhi, India.
  • Nayak K; Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Chawla YM; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Maheshwari D; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Singh P; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Sharma P; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Bhatnagar P; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Kumar S; Department of Biotechnology, School of Chemical and Life Sciences, New Delhi, India.
  • Gottimukkala K; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Panda H; TERI School of Advanced Studies, New Delhi, India.
  • Gunisetty S; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Davis CW; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Kissick HT; ICGEB-Emory Vaccine Center, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Kabra SK; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Lodha R; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Medigeshi GR; Department of Microbiology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ahmed R; Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Murali-Krishna K; Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Chandele A; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
J Virol ; 95(23): e0061021, 2021 11 09.
Article en En | MEDLINE | ID: mdl-34523972
ABSTRACT
Plasmablasts represent a specialized class of antibody-secreting effector B cells that transiently appear in blood circulation following infection or vaccination. The expansion of these cells generally tends to be massive in patients with systemic infections such as dengue or Ebola that cause hemorrhagic fever. To gain a detailed understanding of human plasmablast responses beyond antibody expression, here, we performed immunophenotyping and RNA sequencing (RNA-seq) analysis of the plasmablasts from dengue febrile children in India. We found that plasmablasts expressed several adhesion molecules and chemokines or chemokine receptors that are involved in endothelial interactions or homing to inflamed tissues, including skin, mucosa, and intestine, and upregulated the expression of several cytokine genes that are involved in leukocyte extravasation and angiogenesis. These plasmablasts also upregulated the expression of receptors for several B-cell prosurvival cytokines that are known to be induced robustly in systemic viral infections such as dengue, some of which generally tend to be relatively higher in patients manifesting hemorrhage and/or shock than in patients with mild febrile infection. These findings improve our understanding of human plasmablast responses during the acute febrile phase of systemic dengue infection. IMPORTANCE Dengue is globally spreading, with over 100 million clinical cases annually, with symptoms ranging from mild self-limiting febrile illness to more severe and sometimes life-threatening dengue hemorrhagic fever or shock, especially among children. The pathophysiology of dengue is complex and remains poorly understood despite many advances indicating a key role for antibody-dependent enhancement of infection. While serum antibodies have been extensively studied, the characteristics of the early cellular factories responsible for antibody production, i.e., plasmablasts, are only beginning to emerge. This study provides a comprehensive understanding of the transcriptional profiles of human plasmablasts from dengue patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Inmunofenotipificación / Dengue Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Virol Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Inmunofenotipificación / Dengue Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Virol Año: 2021 Tipo del documento: Article País de afiliación: India
...